STUDY TO EVALUATE ON COMPLIANCES WITH THE ADA GUIDELINES FOR STATIN THERAPY AMONG PATIENTS OF TYPE II DIABETES MELLITUS NON CARDIAC VARIANT IN A TERTIARY CARE TEACHING HOSPITAL, KARNATAKA, SOUTH INDIA. – A STANDARD BASED CLINICAL AUDIT
Abstract
Background: - Based on the recent update of the 2019 American Diabetes Assosciation guidelines for medical care in Diabetes Mellitus patients, initiation of Statin therapy is now a recommended for all patients with risk factors and patient aged more than 40yrs even without risk factors.
Aim & Objectives:- To improve the care being provided to patients with Diabetes mellitus within the organization
Methods: - It was Retrospective, analytical, standard based clinical audit of patient care. The study setting was a tertiary care, teaching hospital in Mysuru city. All the patients were screened for usage of statins and their intensity in different age group and tabulated. The data was analysed and results were interpreted and concluded.
Results:- Out of 32 patients there were 20 male patients and 12 Female. Majority of patient were 40 years and above. Out of 32 patients, 24 patients had risk factors. 3 out of 6 diabetic patients in the age group <40 years with risk factors and received statin therapy. 4 out of 6 diabetic patients with no risk factors aged more than 40 years received statin therapy.15 out of 18 diabetic patients with Atherosclerotic Cardiovascular Disease risk factors with age of 40 and above received Statin therapy.
Conclusion: - In conclusion, this audit shows there is a gap between guidelines and clinical practice in the provision of statin therapy diabetes care. Overall, statin use is beneficial and should be recommended in diabetic patients to target their increased Cardiovascular Disease risk. The quality of care was found to be suboptimal; however, by motivating the primary care doctors via combinations of health care professional education, audit and peer review, the quality of diabetes care in study setting could be improved.
Keywords
Full Text:
PDFReferences
Ramachandran A and Snehalatha C. Epidemology and basic considerations of Diabetes. In: API Textbook of Medicine. 10th ed. mumbai: Jaypee Brothers Medical Publishers LTD; 2015. p. 457.
World Health Organization. The World Health Report 2002: Reducing Risk, Promoting Healthy Life. Geneva, World Health Organization, 2002.
SG Sazlina, AH Zailinawati, A Zaiton & I Ong. A Clinical Audit on Diabetes Care in Two Urban Public Primary Care Clinics in Malaysia. Malaysian Journal of Medicine and Health Sciences. 2010 Jan;6(1):101–9.
Lin I, Sung J, Sanchez RJ, Mallya UG, Friedman M, Panaccio M, et al. Patterns of statin use in a real-world population of patients at high cardiovascular risk. J Manag Care Spec Pharm. 2016;22:685–98.
Katsiki N, Athyros VG, Karagiannis A, Mikhailidis DP. The role of statins in the treatment of type 2 diabetes mellitus: an update. Current Pharmaceutical design. 2014;20(22):3665–74.
Standards of medical care in diabetes--2017: summary of revisions. Diabetes Care 2017; 40: S4-5.
Valensi P,Picard S. Lipids, lipid-lowering therapy and diabetes complications. Diabetes Met. 2011;37:15–24.
National Institute for Clinical Excellence (2002). Principles for Best Practice in Clinical Audit. Oxford: Radcliffe Medical Press Ltd.
Rajakumar MK. Preventing diabetes: the task of the family doctor. AP Fam Med. 2003;2:8–9.
Darshana Bennadi, Vinayak Konekerr, Nandita Kshetrimayum, Sibyl S, Veera Reddy. Clinical Audit - A Literature Review. journal of international dental and medical research. 2014;7(2):49–55.
Buse JB, Ginsberg HN, Bakris GL,Clark NG, Costa F, Eckel R, Fonseca V, Gerstein HC, Grundy S, Nesto RW, Pignone MP, Plutzky J, Porte D, Redberg R, Stitzel KF, Stone NJ. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation. 2007;115:114–26.
Refbacks
- There are currently no refbacks.